Features on Endoscopy and MRI after Treatment with Contact X-ray Brachytherapy for Rectal Cancer: Explorative Results

After neoadjuvant (chemo)radiotherapy for rectal cancer, contact X-ray brachytherapy (CXB) can be applied aiming at organ preservation. This explorative study describes the early features on endoscopy and MRI after CXB. Patients treated with CXB following (chemo)radiotherapy and a follow-up of ≥12 m...

Full description

Bibliographic Details
Main Authors: Petra A. Custers, Monique Maas, Doenja M. J. Lambregts, Regina G. H. Beets-Tan, Geerard L. Beets, Femke P. Peters, Corrie A. M. Marijnen, Monique E. van Leerdam, Inge L. Huibregtse, Baukelien van Triest
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/22/5565
_version_ 1797465705524756480
author Petra A. Custers
Monique Maas
Doenja M. J. Lambregts
Regina G. H. Beets-Tan
Geerard L. Beets
Femke P. Peters
Corrie A. M. Marijnen
Monique E. van Leerdam
Inge L. Huibregtse
Baukelien van Triest
author_facet Petra A. Custers
Monique Maas
Doenja M. J. Lambregts
Regina G. H. Beets-Tan
Geerard L. Beets
Femke P. Peters
Corrie A. M. Marijnen
Monique E. van Leerdam
Inge L. Huibregtse
Baukelien van Triest
author_sort Petra A. Custers
collection DOAJ
description After neoadjuvant (chemo)radiotherapy for rectal cancer, contact X-ray brachytherapy (CXB) can be applied aiming at organ preservation. This explorative study describes the early features on endoscopy and MRI after CXB. Patients treated with CXB following (chemo)radiotherapy and a follow-up of ≥12 months were selected. Endoscopy and MRI were performed every 3 months. Expert readers scored all the images according to structured reporting templates. Thirty-six patients were included, 15 of whom obtained a cCR. On endoscopy, the most frequently observed feature early in follow-up was an ulcer, regardless of whether patients developed a cCR. A flat, white scar and tumor mass were common at 6 months. Focal tumor signal on T2W-MRI and mass-like high signal on DWI were generally absent in patients with a cCR. An ulceration on T2W-MRI and “reactive” mucosal signal on DWI were observed early in follow-up regardless of the final tumor response. The distinction between a cCR and a residual tumor generally can be made at 6 months. Features associated with a residual tumor are tumor mass on endoscopy, focal tumor signal on T2W-MRI, and mass-like high signal on DWI. Early recognition of these features is necessary to identify patients who will not develop a cCR as early as possible.
first_indexed 2024-03-09T18:26:16Z
format Article
id doaj.art-5156bb50d7ae4adf885fa801937afc8f
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T18:26:16Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-5156bb50d7ae4adf885fa801937afc8f2023-11-24T07:53:15ZengMDPI AGCancers2072-66942022-11-011422556510.3390/cancers14225565Features on Endoscopy and MRI after Treatment with Contact X-ray Brachytherapy for Rectal Cancer: Explorative ResultsPetra A. Custers0Monique Maas1Doenja M. J. Lambregts2Regina G. H. Beets-Tan3Geerard L. Beets4Femke P. Peters5Corrie A. M. Marijnen6Monique E. van Leerdam7Inge L. Huibregtse8Baukelien van Triest9Department of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek, P.O. Box 90203, 1006 BE Amsterdam, The NetherlandsDepartment of Radiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, P.O. Box 90203, 1006 BE Amsterdam, The NetherlandsDepartment of Radiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, P.O. Box 90203, 1006 BE Amsterdam, The NetherlandsGROW School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The NetherlandsDepartment of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek, P.O. Box 90203, 1006 BE Amsterdam, The NetherlandsDepartment of Radiation Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, P.O. Box 90203, 1006 BE Amsterdam, The NetherlandsDepartment of Radiation Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, P.O. Box 90203, 1006 BE Amsterdam, The NetherlandsDepartment of Gastroenterology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, P.O. Box 90203, 1006 BE Amsterdam, The NetherlandsDepartment of Gastroenterology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, P.O. Box 90203, 1006 BE Amsterdam, The NetherlandsDepartment of Radiation Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, P.O. Box 90203, 1006 BE Amsterdam, The NetherlandsAfter neoadjuvant (chemo)radiotherapy for rectal cancer, contact X-ray brachytherapy (CXB) can be applied aiming at organ preservation. This explorative study describes the early features on endoscopy and MRI after CXB. Patients treated with CXB following (chemo)radiotherapy and a follow-up of ≥12 months were selected. Endoscopy and MRI were performed every 3 months. Expert readers scored all the images according to structured reporting templates. Thirty-six patients were included, 15 of whom obtained a cCR. On endoscopy, the most frequently observed feature early in follow-up was an ulcer, regardless of whether patients developed a cCR. A flat, white scar and tumor mass were common at 6 months. Focal tumor signal on T2W-MRI and mass-like high signal on DWI were generally absent in patients with a cCR. An ulceration on T2W-MRI and “reactive” mucosal signal on DWI were observed early in follow-up regardless of the final tumor response. The distinction between a cCR and a residual tumor generally can be made at 6 months. Features associated with a residual tumor are tumor mass on endoscopy, focal tumor signal on T2W-MRI, and mass-like high signal on DWI. Early recognition of these features is necessary to identify patients who will not develop a cCR as early as possible.https://www.mdpi.com/2072-6694/14/22/5565rectal cancerorgan preservationcontact X-ray brachytherapyimagingMRIendoscopy
spellingShingle Petra A. Custers
Monique Maas
Doenja M. J. Lambregts
Regina G. H. Beets-Tan
Geerard L. Beets
Femke P. Peters
Corrie A. M. Marijnen
Monique E. van Leerdam
Inge L. Huibregtse
Baukelien van Triest
Features on Endoscopy and MRI after Treatment with Contact X-ray Brachytherapy for Rectal Cancer: Explorative Results
Cancers
rectal cancer
organ preservation
contact X-ray brachytherapy
imaging
MRI
endoscopy
title Features on Endoscopy and MRI after Treatment with Contact X-ray Brachytherapy for Rectal Cancer: Explorative Results
title_full Features on Endoscopy and MRI after Treatment with Contact X-ray Brachytherapy for Rectal Cancer: Explorative Results
title_fullStr Features on Endoscopy and MRI after Treatment with Contact X-ray Brachytherapy for Rectal Cancer: Explorative Results
title_full_unstemmed Features on Endoscopy and MRI after Treatment with Contact X-ray Brachytherapy for Rectal Cancer: Explorative Results
title_short Features on Endoscopy and MRI after Treatment with Contact X-ray Brachytherapy for Rectal Cancer: Explorative Results
title_sort features on endoscopy and mri after treatment with contact x ray brachytherapy for rectal cancer explorative results
topic rectal cancer
organ preservation
contact X-ray brachytherapy
imaging
MRI
endoscopy
url https://www.mdpi.com/2072-6694/14/22/5565
work_keys_str_mv AT petraacusters featuresonendoscopyandmriaftertreatmentwithcontactxraybrachytherapyforrectalcancerexplorativeresults
AT moniquemaas featuresonendoscopyandmriaftertreatmentwithcontactxraybrachytherapyforrectalcancerexplorativeresults
AT doenjamjlambregts featuresonendoscopyandmriaftertreatmentwithcontactxraybrachytherapyforrectalcancerexplorativeresults
AT reginaghbeetstan featuresonendoscopyandmriaftertreatmentwithcontactxraybrachytherapyforrectalcancerexplorativeresults
AT geerardlbeets featuresonendoscopyandmriaftertreatmentwithcontactxraybrachytherapyforrectalcancerexplorativeresults
AT femkeppeters featuresonendoscopyandmriaftertreatmentwithcontactxraybrachytherapyforrectalcancerexplorativeresults
AT corrieammarijnen featuresonendoscopyandmriaftertreatmentwithcontactxraybrachytherapyforrectalcancerexplorativeresults
AT moniqueevanleerdam featuresonendoscopyandmriaftertreatmentwithcontactxraybrachytherapyforrectalcancerexplorativeresults
AT ingelhuibregtse featuresonendoscopyandmriaftertreatmentwithcontactxraybrachytherapyforrectalcancerexplorativeresults
AT baukelienvantriest featuresonendoscopyandmriaftertreatmentwithcontactxraybrachytherapyforrectalcancerexplorativeresults